Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2021

Apr 26, 2021

BUY
$15.31 - $26.52 $55,116 - $95,472
3,600 Added 128.57%
6,400 $48,000
Q3 2020

Oct 27, 2020

SELL
$16.2 - $25.7 $17,820 - $28,270
-1,100 Reduced 28.21%
2,800 $5,000
Q2 2020

Jul 22, 2020

BUY
$5.24 - $23.4 $20,436 - $91,260
3,900 New
3,900 $6,000

Others Institutions Holding MRSN

About Mersana Therapeutics, Inc.


  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $74.8M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.